Introduction
Third molar surgery is the most common procedure carried out by oral and maxillofacial surgeons, and it is a common model for evaluating the efficacy of analgesics for acute dental pain relief (1) . Pain associated with surgical removal of mandibular third molars ranges between moderate and severe during the first 24 hours (h) after surgery, with pain peaking between 6 and 8 h when a conventional local anesthetic is used (2) . It has been suggested that preemptive analgesia is an alternative for treating the postsurgical pain associated with third molar removal (3) . Various analgesics have been used for this purpose, including nonsteriodal anti-inflammatory drugs (NSAIDs) and some opioids (4, 5) . Ketorolac is an NSAID that has been shown to be effective after oral and parenteral administration. As with other NSAIDs, ketorolac produces its effect through the inhibition of prostaglandin synthesis, the fatty acid that promotes pain. Because of its efficacy and high potency, additional mechanisms of action have been proposed, including a modulator effect on opioid receptors and stimulation of nitric oxide release (6) . Tramadol is an opioid analgesic (OA) that is clinically effective in treating moderate to severe pain; it has a low addiction potential. It is used against multiple acute pain conditions, including postsurgical pain. It acts on opioid receptors and seems to modify the transmission of pain, inhibiting the reuptake of monoamines (7) . Previously, we reported that local submucous tramadol administration is effective in reducing pain after impacted mandibular third molar removal (8) , as well as prolonging the time of local anesthesia produced by articaine (9) . The objective of this study was to compare the preemptive analgesia of oral ketorolac plus submucous (s.m.) local placebo with oral ketorolac plus s.m. local tramadol after impacted mandibular third molar surgery. Our hypothesis is that oral ketorolac plus s.m. local tramadol administered preoperatively produces a superior postoperative analgesic effect compared with oral ketorolac plus s.m. local placebo.
Materials and Methods
This study was a double-blind, randomized, placebocontrolled clinical trial conducted in accordance with the Declaration of Helsinki. The Ethics Committee of the Faculty of Dentistry at San Luis Potosí University, Mexico, approved this study. All subjects were informed of the possible risks of oral surgery and treatments used. Each patient accepted and signed an informed consent form. The sample size was calculated as 15 patients in each group with a type I error of 0.05 and statistical power of 80%, using as response variable the first analgesic rescue medication for postoperative pain. One hundred and twenty minutes (min.) was considered a significant clinical difference, with an estimated mean SD of 113 min. obtained in a previous study that evaluated the efficacy of tramadol administered in a combination of routes for reducing pain after removal of an impacted mandibular third molar (7) . Accordingly, we obtained a total of 13 patients but, allowing for a possible loss of 10% in each group, 15 patients were included. Our reasoning was that this number of patients was considered acceptable to demonstrate significant differences attributable to the experimental therapy used. Inclusion criteria were as follows: age 18 to 25 years, either gender, free of systemic disease, clinical and radiographic diagnosis of an impacted mandibular third molar, no pain associated with the subject third molar up to the day of the surgery, and grade II or III difficulty of extraction. Exclusion criteria included the use of analgesics 24 h before the procedure, history of seizure disorder, pregnancy or lactation, oral contraceptive use, known hypersensitivity to the study medications. Patients were randomized into two treatment groups, each with 15 patients, using a series of random numbers: Group A, oral ketorolac 10 mg, 30 min. before surgery plus s.m. local placebo (1 millilitre (ml) saline solution); Group B, oral ketorolac 10 mg plus s.m. local tramadol 50 mg diluted in 1 ml saline solution. All surgical procedures were carried out in the Department of Oral and Maxillofacial Surgery by the same surgeon, and evaluations were carried out by an independent investigator. Anesthesia was by nerve block of the lingual, buccal, and inferior alveolar nerves using two 1.8-mL capsules of 4% articaine containing 1:100,000 epinephrine (Medicaine, Septodont, France), after tramadol or a placebo were administered in the same area using an insulin syringe. Once anesthesia was obtained, surgery was started. A mucoperiosteal flap was prepared by making an incision distal to the lower second molar along the anterior edge of the ascending ramus of the mandible. This flap was used to close the surgical wound. Suturing was done with 4-0 silk. Difficulty of extraction was based on a modified scale of Parant, as follows: Grade I, extraction with forceps and elevators; Grade II, extraction by osteotomy; Grade III, extraction by osteotomy and coronal section; Grade IV, extraction by osteotomy, root and coronal section; Grade V, complex extraction; Grade Vl, extraction with special techniques. In all cases, duration of the operation (from incision to final suture) was recorded. In each patient, a partial bony impacted mandibular third molar was extracted. A 100-mm visual analog scale (VAS) was used to assess pain. The VAS consisted of an interval scale ranging from 0, representing no pain or discomfort, to 100, representing maximum pain or discomfort. The VAS report was recorded each hour for 12 h after comple-e778 tion of surgery, and a last evaluation was done at 24 h postsurgery. Patients were given four oral ketorolac 10 mg pills and were instructed to take one pill for rescue analgesic medication at least 6 hours apart, according to their requirements. An evaluation format was given to each patient to document the time of taking the first ketorolac after the surgery. At the end of the evaluation period (24 h), the patients returned the unused ketorolac. The pills were counted (also those patients in each group not needing any pills) to determine the number of consumed pills. Those patients having no pain relief 30 min. after taking oral ketorolac 10 mg were given Ketorolac 30 mg sublingual as a rescue analgesic. Patients were contacted by telephone the evening of the surgery to assess the incidence of adverse events or symptoms, either from medications or surgical complications; they returned to the clinic after 1 week for suture removal. Both patients and the independent evaluator were blinded regarding the administered treatment. Qualitative variable data are expressed as percentages or proportions. The Fisher exact test was used for statistical analysis of nominal variables, and the MannWhitney U test was employed for ordinal variables. For quantitative variables, the data are shown as means and standard deviations. If the variable presented a normal distribution, the Student t test was utilized; when this requirement was not met, the Mann-Whitney U test was used. We carried out time-event curves to indicate the percentage of patients in each group not taking analgesics. These percentages were compared using the Log-Rank test. For all tests, a difference was considered significant if the probability that it occurred by chance alone was less than 5% (P < 0.05).
Results
Demographic characteristics and variables describing the difficulty of surgery were similar among the groups (Table 1) . (Fig. 1) shows the pain intensity evaluated with the VAS. The time for the first rescue analgesic medication postsurgery was not significantly statistically different (P > .05), but the number of patients who took ketorolac 10 mg orally as the first rescue analgesic was significantly less in group B (P < .05). The number in each group not requiring any rescue analgesic medication during the period of evaluation (24 h) showed a statistically significant difference (P < 0.05) ( Table 2) . Patients taking rescue analgesic medication throughout the 12 h are shown on the time-event curve in (Fig. 2) . The curves show the time at which each patient consumed the first rescue analgesic medication and the percentage of patients in each group who had not received any rescue analgesic (P < 0.05). The end of each curve indicates the proportion of patients in each group who did not take the first rescue analgesic medication during the first 12 h after surgery (P < 0.05). Total analgesic consumption for group A was significantly great than that of group B (P < 0.05). During the evaluation period, two group A patients required rescue (Table 2 ). There were no complications associated with the surgical procedure itself, and no patients reported adverse events associated with the medications.
Discussion
This study demonstrated that oral administration of 10 mg ketorolac plus 50 mg of tramadol administered s.m. showed clear differences in the need for postoperative analgesic consumption compared with the group receiving 10 mg oral ketorolac plus a local placebo s.m. We found that only 1 patient in group A needed no pain medication within 12 h after surgery compared with 10 patients from group B. We found statistically significant differences between groups in pain intensity measured by VAS at 6 h postsurgery. However, it seems that this difference evaluated by itself does not have clinical significance for pain relief because of its subjective assessment; however, we consider the clear difference in analgesic consumption after treatment to be clinically relevant.
The topic of preemptive analgesia is controversial; there have been reports in favor as well those against. For this reason, some guidelines have been developed to assess the quality of reports of randomized clinical trials in pain research. It has been reported that blind assessments produce significantly lower and more consistent
scores than do open assessments (10) . Furthermore, a meta-analysis by Ong et al. (11) assessing the ability of preemptive analgesic interventions to attenuate postoperative pain scores, decrease postoperative analgesic requirements, and prolong the time to first rescue analgesia demonstrated an overall beneficial effect in selected analgesic regimens that was most pronounced after epidural analgesia, local wound infiltrations, and systemic NSAID administration. This meta-analysis also showed many deficiencies in the design of randomized clinical trials in the field of oral surgery. Pre-or postoperative administration of 550 mg naproxen or 1,000 mg diflunisal orally produces good pain relief after surgical removal of impacted third molars. However, no significant differences were found in either study about pain relief between the pre-and postopera-erative approaches (12, 13) . A study using preemptive analge-13). A study using preemptive analgesia showed that tramadol 50 mg intravenous (i.v.) is more effective than oral tramadol 50 mg in relieving pain after third molar surgery (14) . Another study demonstrated that ketorolac 30 mg i.v. produces better preventive analgesic efficacy than tramadol 50 mg i.v. when administered preoperatively in third molar surgery (15) . One approach to overcoming these therapeutic limitations is to maximize drug levels at the site of action and minimize systemic exposure by administering the drug directly to the site of tissue injury. Local application of aspirin and acetaminophen at subtherapeutic doses (50 mg) has been shown to produce analgesia superior to the placebo (16) . An aspirin solution applied topically in the oral cavity has an analgesic effect on experimental and clinical pain, which appears to be mediated locally and not by systemic absorption (17). Ketoprofen 10 mg administered into the two mandibular extraction sites showed better analgesic efficacy than a 25-mg ketoprofen oral capsule. In addition, plasma concentrations of 10-mg ketoprofen were lower than the 25-mg oral capsule of ketoprofen (18) . We believe that the local administration of analgesics may also be an acceptable alternative to the use of NSAIDs in the oral cavity, particularly in patients with increased risk of gastrointestinal bleeding after enteral administration (19, 20) . On the other hand, reduction in plasma concentration of any NSAID is desirable owing to alterations in renal function associated with the ingestion of these drugs, which are estimated to occur in approximately 1% of exposed patients (21) .
The main finding of this study is that, in patients undergoing removal of an impacted mandibular third molar, treatment with preemptive ketorolac plus s.m. local tramadol resulted in an important reduction in consumption of postoperative analgesics. This study suggests that the use of ketorolac, along with s.m. local tramadol in a regimen of preemptive analgesia, represents an alternative for the treatment of acute pain after removal of an impacted mandibular third molar.
